Frank Moriarty
@frankmoriarty.bsky.social
Associate professor, researcher and pharmacist at the School of Pharmacy and Biomolecular Sciences, RCSI. Interested in pharmacoepi, deprescribing, and open research.
Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing.
More information about the DIAMOND programme available at: diamond-deprescribing.eu
Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
More information about the DIAMOND programme available at: diamond-deprescribing.eu
Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
June 27, 2025 at 9:28 AM
Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing.
More information about the DIAMOND programme available at: diamond-deprescribing.eu
Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
More information about the DIAMOND programme available at: diamond-deprescribing.eu
Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
Reposted by Frank Moriarty
A conference exploring how clinical research, medication safety and patient empowerment could impact national initiatives to support ageing adults took place in Dublin today, organised by @rcsipophealth.bsky.social and @tcddublin.bsky.social
June 25, 2025 at 3:33 PM
A conference exploring how clinical research, medication safety and patient empowerment could impact national initiatives to support ageing adults took place in Dublin today, organised by @rcsipophealth.bsky.social and @tcddublin.bsky.social
Reposted by Frank Moriarty
#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience
June 20, 2025 at 3:57 PM
#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience
Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social!
If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
June 23, 2025 at 2:14 PM
Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social!
If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
Reposted by Frank Moriarty
This early access original research study identifies five clinically relevant prescribing cascades in a national sample of more than half a million older adults in Ireland. #FMsky#Medsky #PrimaryCare
www.annfammed.org/content/earl...
www.annfammed.org/content/earl...
June 11, 2025 at 3:50 PM
This early access original research study identifies five clinically relevant prescribing cascades in a national sample of more than half a million older adults in Ireland. #FMsky#Medsky #PrimaryCare
www.annfammed.org/content/earl...
www.annfammed.org/content/earl...
Reposted by Frank Moriarty
On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds.
We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for.
shorturl.at/erwpH
We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for.
shorturl.at/erwpH
Should the maker of Ozempic be funding children’s playgrounds in Ireland?
In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals
shorturl.at
June 3, 2025 at 3:38 PM
On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds.
We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for.
shorturl.at/erwpH
We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for.
shorturl.at/erwpH
Reposted by Frank Moriarty
Well done to WP lead Ryan Muddiman & review co-authors: Florencia Ines Aiello Battan, John Tazare, @annaschultze.bsky.social, Teresa Perez, Li Wei, @fionaboland.bsky.social, @marywalsh14.bsky.social @frankmoriarty.bsky.social #CausalInference #Deprescribing #DIAMOND diamond-deprescribing.eu
Home
DIAMOND is an ambitious Wellcome-funded programme of research that aims to develop and advance novel methods for researching deprescribing by harnessing big data.
diamond-deprescribing.eu
May 29, 2025 at 3:06 PM
Well done to WP lead Ryan Muddiman & review co-authors: Florencia Ines Aiello Battan, John Tazare, @annaschultze.bsky.social, Teresa Perez, Li Wei, @fionaboland.bsky.social, @marywalsh14.bsky.social @frankmoriarty.bsky.social #CausalInference #Deprescribing #DIAMOND diamond-deprescribing.eu
Reposted by Frank Moriarty
DIAMOND WP2 is exploring how simulation can support target trial emulation in deprescribing research. We recently conducted a review of simulation studies - 📢preprint now here: doi.org/10.1101/2025....
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
Pharmacoepidemiology simulation study practices: A methodological review
Purpose Simulation studies are used in pharmacoepidemiology for evaluating inferential methods in a controlled setting, whereby a known data-generating mechanism allows evaluation of the performance o...
doi.org
May 29, 2025 at 3:06 PM
DIAMOND WP2 is exploring how simulation can support target trial emulation in deprescribing research. We recently conducted a review of simulation studies - 📢preprint now here: doi.org/10.1101/2025....
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
Last few days to apply for this funded PhD on deprescribing in chronic kidney disease, closes on Monday 2nd June!
We're looking for a PhD scholar for a @hrbireland.bsky.social funded 4-year project focused on prescribing and deprescribing in chronic kidney disease, based at @rcsi.bsky.social.
If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
Enhancing prescribing In chronic kidney disease in primary care (EPIC)
The overall research project aims to develop a comprehensive set of indicators to guide medicines optimisation and deprescribing in people with CKD in primary care. More ...
www.rcsi.com
May 28, 2025 at 12:11 PM
Last few days to apply for this funded PhD on deprescribing in chronic kidney disease, closes on Monday 2nd June!
Reposted by Frank Moriarty
Publication: We modelled the impact of post-2016 changes to prescription medicine co-payment charges and cost caps on out-of-pocket prescription expenditure
Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555
shorturl.at/l7OAh
Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555
shorturl.at/l7OAh
Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults
To assess impacts of government changes to prescription medicine co-payments on individuals’ out-of-pocket expenditure.Participants were community-dwe…
www.sciencedirect.com
May 28, 2025 at 8:46 AM
Publication: We modelled the impact of post-2016 changes to prescription medicine co-payment charges and cost caps on out-of-pocket prescription expenditure
Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555
shorturl.at/l7OAh
Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555
shorturl.at/l7OAh
We're looking for a PhD scholar for a @hrbireland.bsky.social funded 4-year project focused on prescribing and deprescribing in chronic kidney disease, based at @rcsi.bsky.social.
If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
Enhancing prescribing In chronic kidney disease in primary care (EPIC)
The overall research project aims to develop a comprehensive set of indicators to guide medicines optimisation and deprescribing in people with CKD in primary care. More ...
www.rcsi.com
May 16, 2025 at 12:12 PM
We're looking for a PhD scholar for a @hrbireland.bsky.social funded 4-year project focused on prescribing and deprescribing in chronic kidney disease, based at @rcsi.bsky.social.
If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
Reposted by Frank Moriarty
Great 2nd DIAMOND Steering Group meeting today on #WorldHealthDay, bringing together diverse expertise in:
📈 Biostatistics & Data Science
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures
📈 Biostatistics & Data Science
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures
April 7, 2025 at 7:46 PM
Great 2nd DIAMOND Steering Group meeting today on #WorldHealthDay, bringing together diverse expertise in:
📈 Biostatistics & Data Science
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures
📈 Biostatistics & Data Science
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures
Reposted by Frank Moriarty
Excited to be part of this innovative programme of work @rcsi.bsky.social led by my long-time colleague @frankmoriarty.bsky.social. It has the potential to transform #bigdata research in this field, making it transparent and reproducible, informing challenging clinical decisions globally! 🌍 #DIAMOND
Medication needs change across life. On #WorldHealthDay, we launch DIAMOND: Developing Innovative Analytical Methods for research ON Deprescribing. Funded by Wellcome, this research advances methods for studying effects of deprescribing using big data. 🌐 www.diamond-deprescribing.eu #HopefulFutures
April 8, 2025 at 7:46 AM
Excited to be part of this innovative programme of work @rcsi.bsky.social led by my long-time colleague @frankmoriarty.bsky.social. It has the potential to transform #bigdata research in this field, making it transparent and reproducible, informing challenging clinical decisions globally! 🌍 #DIAMOND
We're officially launching the DIAMOND research programme today, hosted by @rcsi.bsky.social.
Our research focuses on #deprescribing and #bigdata, check out our website below for more information and follow for updates 👇
Our research focuses on #deprescribing and #bigdata, check out our website below for more information and follow for updates 👇
Medication needs change across life. On #WorldHealthDay, we launch DIAMOND: Developing Innovative Analytical Methods for research ON Deprescribing. Funded by Wellcome, this research advances methods for studying effects of deprescribing using big data. 🌐 www.diamond-deprescribing.eu #HopefulFutures
April 7, 2025 at 2:28 PM
We're officially launching the DIAMOND research programme today, hosted by @rcsi.bsky.social.
Our research focuses on #deprescribing and #bigdata, check out our website below for more information and follow for updates 👇
Our research focuses on #deprescribing and #bigdata, check out our website below for more information and follow for updates 👇
Reposted by Frank Moriarty
Planning for ICOD3 has launched! 🚀
The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.
Stay tuned for more info: official dates and venue are coming soon! 👀
The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.
Stay tuned for more info: official dates and venue are coming soon! 👀
March 19, 2025 at 2:14 PM
Planning for ICOD3 has launched! 🚀
The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.
Stay tuned for more info: official dates and venue are coming soon! 👀
The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.
Stay tuned for more info: official dates and venue are coming soon! 👀
Very pleased to launch RxTrends, a tool to visualise open data on medication prescribing in Ireland: cdrx-project.eu/rxtrends/.
It was developed by Dr Ahmed Hassan Ali as part of the HRB-funded CDRx project. You can read more about the tool in the companion paper: hrbopenresearch.org/articles/8-36
It was developed by Dr Ahmed Hassan Ali as part of the HRB-funded CDRx project. You can read more about the tool in the companion paper: hrbopenresearch.org/articles/8-36
March 14, 2025 at 11:30 AM
Very pleased to launch RxTrends, a tool to visualise open data on medication prescribing in Ireland: cdrx-project.eu/rxtrends/.
It was developed by Dr Ahmed Hassan Ali as part of the HRB-funded CDRx project. You can read more about the tool in the companion paper: hrbopenresearch.org/articles/8-36
It was developed by Dr Ahmed Hassan Ali as part of the HRB-funded CDRx project. You can read more about the tool in the companion paper: hrbopenresearch.org/articles/8-36